Gadi Toren
Investment Partner @ Bosch Ventures
Tel Aviv, Israel
Gadi Toren is an Investment Partner with RBVC, based in the Tel Aviv office, responsible for the search area of Clean Tech and the Israeli Venture Capital activity of Bosch. Gadi has been active in Venture Capital since 1998, focused primarily on early stage investments. His previous position was with Partech International, heading theirsoftware and Internet Investments in Israel, where he invested and served on the board of PowerID. He spent 6 years as Principal with Apax Partners in Tel Aviv and London where he invested in various companies such as Ceragon Networks (CRNT), Ezchip - merged with Lanoptics (LNOP), Commtouch (CTCH) and Native Networks - sold to Alcatel in 2004. Prior to joining Apax Partners, he was Director and Head of the Product Management group at Elbit Systems Ltd where he led projects in Europe, Asia and the USA. Gadi holds an MBA with Distinction from INSEAD, and a BA Magna Cum Laude in Economics and Management from Tel Aviv University.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Gadi Toren invests in
Stages Gadi Toren invests in
Countries Gadi Toren invests in
Investment Focus
Industry
- Mobile 2 (20%)
- Solar 1 (10%)
- Drones 1 (10%)
- Energy 1 (10%)
- Sensor 1 (10%)
Stage
- Series B 3 (30%)
- Funding Round 2 (20%)
- Seed 1 (10%)
- Series C 1 (10%)
Country
- Israel 2 (20%)
- France 1 (10%)
- Belgium 1 (10%)
- United States 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Prophesee
|
Prophesee is the inventor of the world’s most advanced neuromorphic vision systems.Prophesee’s patented sensors and AI algorithms, introduce a new computer vision paradigm based on how the human eye and brain work. Like the human vision, it sees events: essential, motion information in the scene, not a succession of images.This Metavision®method allows for unprecedented speed (>10 000fps time resolution equivalent), dynamic range (>120dB), data volume (10x to 1000x less) and power efficiency (<10 mW). Prophesee bio-inspired revolution opens a new path to absolute efficiency and safety in autonomous driving, Mobile, IoT and Industry 4.0.Prophesee was founded within iBionext Start-up Studio (Paris) in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch and Luca Verre. The quartet brings a strong combination of experience in image sensing, neuromorphic computing, VLSI design, entrepreneurship and business development. Prophesee is based in Paris, with local offices in Grenoble, Shanghai, Tokyo and Silicon Valley. The company is driven by a team of more than 100 visionary engineers, holds more than 50 international patents and is backed by leading international equity and corporate investors including 360 Capital Partners, European Investment Bank, iBionext, Inno-Chip, Intel Capital, Renault Group, Robert Bosch Venture Capital, Sinovation, Supernova Invest, Xiaomi. | $26.9M / Series B / Oct 28, 2019 | |
|
Prophesee
|
Prophesee is the inventor of the world’s most advanced neuromorphic vision systems.Prophesee’s patented sensors and AI algorithms, introduce a new computer vision paradigm based on how the human eye and brain work. Like the human vision, it sees events: essential, motion information in the scene, not a succession of images.This Metavision®method allows for unprecedented speed (>10 000fps time resolution equivalent), dynamic range (>120dB), data volume (10x to 1000x less) and power efficiency (<10 mW). Prophesee bio-inspired revolution opens a new path to absolute efficiency and safety in autonomous driving, Mobile, IoT and Industry 4.0.Prophesee was founded within iBionext Start-up Studio (Paris) in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch and Luca Verre. The quartet brings a strong combination of experience in image sensing, neuromorphic computing, VLSI design, entrepreneurship and business development. Prophesee is based in Paris, with local offices in Grenoble, Shanghai, Tokyo and Silicon Valley. The company is driven by a team of more than 100 visionary engineers, holds more than 50 international patents and is backed by leading international equity and corporate investors including 360 Capital Partners, European Investment Bank, iBionext, Inno-Chip, Intel Capital, Renault Group, Robert Bosch Venture Capital, Sinovation, Supernova Invest, Xiaomi. | $18.1M / Series B / Feb 21, 2018 | |
Cheetah Medical
|
Cheetah’s proprietary CHEETAH NICOM system is CE marked and FDA cleared. It is the only non-invasive cardiac output monitor with substantial equivalence to the Swan Ganz thermodilution system for U.S. regulatory purposes. The CHEETAH NICOM is now used by leading medical centers around the globe providing clinicians with invaluable clinicalinformation in complicated scenarios. Cheetah Medical is committed to ongoing research and development and close cooperation with clinicians. | $11.8M / Series C / Sep 12, 2017 | |
|
Prophesee
|
Prophesee is the inventor of the world’s most advanced neuromorphic vision systems.Prophesee’s patented sensors and AI algorithms, introduce a new computer vision paradigm based on how the human eye and brain work. Like the human vision, it sees events: essential, motion information in the scene, not a succession of images.This Metavision®method allows for unprecedented speed (>10 000fps time resolution equivalent), dynamic range (>120dB), data volume (10x to 1000x less) and power efficiency (<10 mW). Prophesee bio-inspired revolution opens a new path to absolute efficiency and safety in autonomous driving, Mobile, IoT and Industry 4.0.Prophesee was founded within iBionext Start-up Studio (Paris) in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch and Luca Verre. The quartet brings a strong combination of experience in image sensing, neuromorphic computing, VLSI design, entrepreneurship and business development. Prophesee is based in Paris, with local offices in Grenoble, Shanghai, Tokyo and Silicon Valley. The company is driven by a team of more than 100 visionary engineers, holds more than 50 international patents and is backed by leading international equity and corporate investors including 360 Capital Partners, European Investment Bank, iBionext, Inno-Chip, Intel Capital, Renault Group, Robert Bosch Venture Capital, Sinovation, Supernova Invest, Xiaomi. | $14.9M / Series B / Oct 24, 2016 | |
Utilight
|
Utilight Ltd. is an innovative startup company striving to provide a better way to utilize the suns renewable energy, enabling affordable solar energy for a cleaner world.Utilight invented and is developing a revolutionary printing technology (patents’ pending PTP™ - Pattern Transfer Printing) for an immediate implementation in the PVmetallization process of c-Si solar cells; increasing solar cell efficiency while reducing PV manufacturing costs. In August 2012, after successfully accomplishing the feasibility study, which was backed by angel investors and R&D grants from the Israeli office of Chief Scientist, the company received investments from three venture funds towards the development of commercial products for the solar PV industry. The company has developed strategic partnerships with leading solar cell manufacturers in China and Taiwan. | $2.9M / Mar 07, 2016 | |
|
Prophesee
|
Prophesee is the inventor of the world’s most advanced neuromorphic vision systems.Prophesee’s patented sensors and AI algorithms, introduce a new computer vision paradigm based on how the human eye and brain work. Like the human vision, it sees events: essential, motion information in the scene, not a succession of images.This Metavision®method allows for unprecedented speed (>10 000fps time resolution equivalent), dynamic range (>120dB), data volume (10x to 1000x less) and power efficiency (<10 mW). Prophesee bio-inspired revolution opens a new path to absolute efficiency and safety in autonomous driving, Mobile, IoT and Industry 4.0.Prophesee was founded within iBionext Start-up Studio (Paris) in 2014 by Ryad Benosman, Bernard Gilly, Christoph Posch and Luca Verre. The quartet brings a strong combination of experience in image sensing, neuromorphic computing, VLSI design, entrepreneurship and business development. Prophesee is based in Paris, with local offices in Grenoble, Shanghai, Tokyo and Silicon Valley. The company is driven by a team of more than 100 visionary engineers, holds more than 50 international patents and is backed by leading international equity and corporate investors including 360 Capital Partners, European Investment Bank, iBionext, Inno-Chip, Intel Capital, Renault Group, Robert Bosch Venture Capital, Sinovation, Supernova Invest, Xiaomi. | $796K / Seed / Sep 16, 2015 | |
|
Cheetah Medical
|
Cheetah’s proprietary CHEETAH NICOM system is CE marked and FDA cleared. It is the only non-invasive cardiac output monitor with substantial equivalence to the Swan Ganz thermodilution system for U.S. regulatory purposes. The CHEETAH NICOM is now used by leading medical centers around the globe providing clinicians with invaluable clinicalinformation in complicated scenarios. Cheetah Medical is committed to ongoing research and development and close cooperation with clinicians. | $28.8M / Series C / Feb 24, 2014 | |
Pebbles Interfaces
|
Pebbles Interfaces technology provides an entirely new meaning to simple and natural human gestures, by unifying the interfaces on any device or platform, be it a smartphone, PC, smart TV, or even a coffee table surface — from any distance.They develop advanced motion sensors that display physical objects within the digital space, at any rangeor angle, with no latency. Pebbles’ minimal hardware is being embedded in their partners’ smart products and devices. These upcoming products are set to reinvent human interaction within the digital world.Following their vision — to naturally interface with every object, real or virtual — Pebbles presents a technology that extends human behavior, enabling simple and intuitive interaction with any consumer electronic device. | $11M / Series B / Aug 01, 2013 | |
EpiGaN
|
EpiGaN, a Leuven, Belgium-based company that develops Gallium Nitride on Silicon (GaN) on-silicon wafers... | $4.2M / Jul 14, 2011 | |
|
Cheetah Medical
|
Cheetah’s proprietary CHEETAH NICOM system is CE marked and FDA cleared. It is the only non-invasive cardiac output monitor with substantial equivalence to the Swan Ganz thermodilution system for U.S. regulatory purposes. The CHEETAH NICOM is now used by leading medical centers around the globe providing clinicians with invaluable clinicalinformation in complicated scenarios. Cheetah Medical is committed to ongoing research and development and close cooperation with clinicians. | $20M / Series B / Apr 06, 2010 |
Co-Investors
About Bosch Ventures
Bosch Ventures (Robert Bosch Venture Capital GmbH) is the corporate venture capital company of the Bosch Group, a leading global supplier of technology and services. Bosch Ventures invests worldwide in innovative start-up companies at all stages of their development. Its investment activities focus on technology companies working in areas ofbusiness of current and future relevance for Bosch, above all, automation and electrification, energy efficiency, enabling technologies, and healthcare systems. Bosch Ventures also invests in services and business models as well as new materials that are relevant to the above-mentioned areas of business.Bosch Ventures invests from EUR 500k for a seed funding to more than EUR 15m per company for usually 10% to 25% equity position. Bosch Ventures prefers to syndicate their investments with existing or new investors in the company and can take the lead as necessary.
Bosch Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ayelet Edrey
Investment Principal
|
|||
Baha Berse
Manager Finance & Controlling, Fund Administration
|
|||
Chris Ferle
Investment Director
|
|||
|
Gadi Toren
Investment Partner
|
|||
Gitte Bedford
Vice President
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Gadi Toren invest in?
Gadi Toren invests primarily in Mobile, Solar and Drones startups, most often at Series B and Funding Round stage. Most of the 10 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Gadi Toren last invest?
The most recent investment recorded for Gadi Toren closed in Oct 2019. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
